| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Shane Ward | COO CLO | 2025-12-10 | 9,959 | $220.08 | $2.19MSell |
| Nicole Negar Davarpanah | Chief Medical Officer | 2025-12-10 | 10,332 | $219.60 | $2.27MSell |
| Frank Karbe | Chief Financial Officer | 2025-12-10 | 7,290 | $219.60 | $1.60MSell |
| Jeffrey Stein | President CEO | 2025-12-10 | 2,285 | $219.60 | $501.79kSell |
| Shane Ward | COO CLO | 2025-12-10 | 15,041 | $219.60 | $3.30MSell |
| Shane Ward | COO CLO | 2025-12-10 | 3,500 | $16.65 | $58.29kBuy |
| Shane Ward | COO CLO | 2025-12-10 | 6,459 | $20.20 | $130.47kBuy |
| Nicole Negar Davarpanah | Chief Medical Officer | 2025-09-11 | 474 | $62.86 | $29.80kSell |
| Ra Capital Management LP | Director | 2025-06-26 | 2,272,727 | $44.00 | $100.00MBuy |
| Chrysa Mineo | Director | 2025-06-03 | 1,050 | $23.44 | $24.61kBuy |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Ag Mundipharma | 15.21% | 4,781,408 | $1.05B | Insider |
| Ra Capital Management LP | 10.70% | 3,365,523 | $740.75M | Institution |
| Ra Capital Management LP | 10.70% | 3,365,523 | $740.75M | Insider |
| Bain Capital Life Sciences Investors LLC | 9.61% | 3,020,990 | $664.92M | Institution |
| Target N. V. Biotech | 7.30% | 2,295,272 | $505.19M | Insider |
| Point72 Asset Management LP | 5.02% | 1,578,069 | $347.33M | Institution |
| Bvf Inc | 4.50% | 1,414,165 | $311.26M | Institution |
| Nina S. Kjellson | 4.32% | 1,356,813 | $298.63M | Insider |
| Vivo Capital LLC | 4.17% | 1,311,425 | $288.64M | Institution |
| Vanguard Group Inc | 3.91% | 1,230,666 | $270.87M | Institution |